Rennova Health, Inc.
RNVA
RNVA was delisted on the 24th of October, 2017.
8 hedge funds and large institutions have $236K invested in Rennova Health, Inc. in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
47% more capital invested
Capital invested by funds: $161K → $236K (+$75K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
11% less funds holding
Funds holding: 9 → 8 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$272K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$123K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$17.2K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$15.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$86K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$24K |
| 3 |
BlackRock
New York
|
-$21 |
RNVA Hedge Fund Activity: Q2 2017 in Review
8 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Rennova Health, Inc. (RNVA) for Q2 2017, worth a combined $236K — up 47% from $161K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of RNVA and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $272K. The largest seller was Morgan Stanley, exiting entirely with an estimated $86K sold.
- 8 institutional investors held Rennova Health, Inc. (RNVA) as of Q2 2017, down from 9 in Q1 2017.
- Funds reported $236K of Rennova Health, Inc. stock for Q2 2017, up 47% quarter-over-quarter.
- 3 funds opened new Rennova Health, Inc. positions in Q2 2017 and 4 closed out, a net change of -1 holder.
- The largest Rennova Health, Inc. buyer in Q2 2017 was Virtu KCG Holdings, an estimated $272K added.
- The largest Rennova Health, Inc. seller in Q2 2017 was Morgan Stanley, an estimated $86K sold.
Based on aggregated 13F filings for Q2 2017.